Summary of the invention
The purpose of the present invention is to provide a kind of construction methods of CXCR4RNAi slow virus carrier.
To achieve the above object, the present invention adopts the following technical scheme:
CXCR4RNAi slow virus carrier, the carrier contain CXCR4 genetic fragment.
The construction method of CXCR4RNAi slow virus carrier includes the following:
(1) interference sequence designs: according to the mRNA complete sequence of GenBank CXCR4, confirming through BLAST sequence analysis special
The secondary structure of said target mrna sequence is assessed using 4.4 software of RNA structure after the opposite sex, obtains 19nt target sequence;
Then it is single-stranded its corresponding two shRNA oligonucleotides to be synthesized for the design of each target sequence;A pair of of control sequence is designed simultaneously
siRNAc;
(2) building and identification of Lentiviral: empty carrier pGC-LV is marked with GFP, by PLVX-shRNA-
PURO vector ring-type empty plasmid BamHAnd EcoRRestriction enzyme carries out double digestion, and recycles PLVX-SHRNA-
PURO vector endonuclease bamhi, connection sky PLVX.1 carrier (coming from clontech company) and shRNA oligonucleotides double-strand, even
The recombinant vector to be formed is connect, connection product converts fresh competent cell E.coli DH5 α, and positive gram is chosen after 37 DEG C of culture 16h
Grand progress bacterium colony PCR identification extracts recombinant plasmid after sequencing result verifies construction of recombinant plasmid success;
(3) QPCR screens the primer that the QPCR primer of shRNA:CXCR4 gene is vector multiple cloning site both ends, culture
Plasmid and lipo2000 compound are added in six orifice plates, 293 cell, extract the RNA of group of cells, RNA is inverted by 293 cells
Record is cDNA, is template using cDNA, utilizes the relative expression quantity of the QPCR primer detection CXCR4 gene, fluorescent quantitation inspection
Survey each group primer;PCR reaction condition: 95 DEG C of 30s, 1 circulation, 55 DEG C of 30s40 circulations, 95 DEG C of 5s, 60 DEG C of 1min, 95 DEG C of 15s.
QPCR primer sequence described in step (3) are as follows: Primer(+): 5 ' GGAGAGTTGTAGGATTCTAC-3 ',
Primer(-):5’-CCTCGGTGTAGTTATCTGAAG-3’。
PLVX-shRNA-PURO vector ring-type empty plasmid is transformed by clontech company carrier PLVX-shRNA2
, concrete mode is: puro expression cassette is cloned into behind PLVX-shRNA2 carrier ZSgreen by amplification puro expression cassette.It is public
The green hyperfluorescence albumen recognized, those skilled in the art can according to said method obtain the plasmid.
The present invention has the advantages that
Slow virus carrier and retroviral vector, adenovirus vector, gland relevant viral vector etc. are compared, and are had below
Advantage: (1) can infect division cells and nondividing phase cell, such as nervous system, hemopoietic system nondividing phase cell, be immunized
It reacts smaller;(2) transferable genetic fragment is larger, can be inserted into the genetic fragment of about 10 kb;(3) virus mutation and have multiple
The viral probability of ability processed is smaller, greatly reduces virus (the replication competent of replication capacity
Virus, RCV);(4) target gene and host genome are by integrating the expression, it can be achieved that the target gene long period.Gene
RNA perturbation technique in treating has become the new method of oncotherapy, and slow virus carrier can safely shift tumour target gene
To body.By the RNAi technology of lentivirus-mediated, influence factor relevant to disease is found, and attempt thus to set about grinding
The method for studying carefully treatment achievees the effect that treat disease.It should also ensure that higher safety, validity and reliability thus, and
Clinical experimental stage gradually is entered from experiment in vitro and zoopery, it is believed that the technology will be in research field and clinic from now on
There is broader prospect in terms of practical application.
Specific embodiment
1 materials and methods
1.1 material
Human lung adenocarcinoma PC9 cell strain is purchased from Shanghai Yu Bo Biotechnology Co., Ltd.Cell DMEM 90%, Fetal
10% culture medium of Bovine Serum, at 37 DEG C, 5%CO2Cell incubator in routine culture.CXCR4 rabbit polyclonal antibody,
GAPDH mouse is mostly anti-to be purchased from abcam company, and the goat antirabbit secondary antibody of horseradish peroxidase-labeled is purchased from abcam company
1.2 method
1.2.1 interference sequence designs
According to the mRNA complete sequence (Accession No:NM_003467) of GenBank CXCR4, through BLAST homology ratio
To applying 4.4 software of RNA structure to assess the secondary structure of said target mrna sequence after confirming specificity, 3 are obtained
19nt target sequence.Then it is single-stranded its corresponding two shRNA oligonucleotides to be synthesized for the design of each target sequence.A pair is designed simultaneously
Control sequence siRNAc.Then it is single-stranded two shRNA oligonucleotides to be synthesized according to the sequence design of siRNA.It designs as follows: BamH+ 19 nt target nucleotide sequences of restriction enzyme site+loop-stem structure (TTCAAGAGA)+target sequence complementary series+RNA PolyPolymerization
Enzyme transcription pausing site (TTTTTT)+EcoRSix regions of restriction enzyme site, be respectively designated as shRNA1, shRNA2,
ShRNA3 and shRNAc, particular sequence are shown in Table 1.ShRNA oligonucleotide chain is synthesized by Shanghai Sangon Biotech Company.
3 specificity SiRNA target sequences of 1. CXCR4 gene of table
1.2.2 the building and identification of Lentiviral
Empty carrier pGC-LV is marked with GFP.By PLVX-shRNA-PURO vector ring-type empty plasmid BamH
And EcoRRestriction enzyme carries out double digestion, and recycles PLVX-SHRNA-PURO vector endonuclease bamhi.Connection is empty
PLVX.1 carrier and shRNA oligonucleotides double-strand, the recombinant vector for connecting formation are respectively labeled as: PLVX-CXCR4shRNA1,
PLVX-CXCR4shRNA2,PLVX-CXCR4shRNA3,PLVX-CXCR4shRNAc.Connection product converts fresh competent cell
E.coli DH5α.Positive colony is chosen after 37 DEG C of culture 16h and carries out bacterium colony PCR identification, is served the raw work in sea and is carried out DNA sequencing identification.
After sequencing result verifies construction of recombinant plasmid success, recombinant plasmid is extracted.
1.2.3 QPCR screens the shRNA of optimum jamming effect
The QPCR primer of CXCR4 gene is the primer at vector multiple cloning site both ends, sequence Primer(+): 5, '
GGAGAGTTGTAGGATTCTAC3’, Primer (-): 5’CCTCGGTGTAGTTATCTGAAG3’,
293 cells are cultivated, by plasmid (pLVX-CXCR4shRNA1, pLVX-CXCR4shRNA2, pLVX-
CXCR4shRNA3, pLVX-acGFP-C1) and lipo2000 compound be added six orifice plates, 293 cell in, extract group of cells
RNA reverse transcription is cDNA by RNA, is template using cDNA, is detected the relative expression quantity of CXCR4 gene, fluorogenic quantitative detection is each
Group primer.PCR reaction condition: 95 DEG C of 30s, 1 circulation, 55 DEG C of 30s40 circulations, 95 DEG C of 5s, 60 DEG C of 1min, 95 DEG C of 15s.With 2-△△CtValue indicates the relative expression levels of CXCR4 gene mRNA.
1.2.4 slow virus is packed
According to interference screening as a result, by the interference carrier PLVX-CXCR4-shRNA1 coated plate of optimum jamming effect, 37 DEG C
Overnight incubation, picking single colonie are inoculated into the LB culture medium of 200ml, 250rpm, and 37 DEG C are shaken bacterium overnight incubation, a large amount of to extract
Plasmid.Mass propgation 293T cell, the day before transfection are anti-with being free of with the 293T cell of trypsin digestion logarithmic growth phase
The DMEM complete medium inoculation 293FT cell of raw element is in 60 mm plates, 2 × 106 cells of each ware inoculating cell, and 37
DEG C, 24 h are cultivated in 5% CO2 incubator.By shRNAc, CXCR4-shRNA respectively with slow virus packaging plasmid cotransfection 293T
Cell.48 h collect the 293T cell supernatant after transfection, and filtrate is concentrated after ultracentrifugation, remove supernatant, and it is following heavy to retain
It forms sediment, suitable PBS lytic virus precipitating is added, is stored in after packing in viral pipe, -80 DEG C of long-term preservations.
1.2.5 virus titer measures
293 cells are cultivated, seed cells into 48 orifice plates, 105, every hole cell, 37 DEG C, 5%CO2 continues to cultivate 18h.It takes
The viral dilution of 20 μ l is to the DMEM culture medium of 200 μ l, and successively 10 dilution viruses are (10-3、10-4、10-5、10-6、10-7), it mixes
Even diluted virus, is added separately in 48 holes, and every 100 μ l of hole, 37 DEG C, 5%CO2 continues to cultivate 48h.It is inverted using fluorescence micro-
The quantity of each pore area fluorecyte of mirror detection statistics, calculate virus titer in conjunction with extension rate: titre (TU/m1)=fluorescence is thin
The effective extension rate of born of the same parents' number X.
1.2.6 the foundation of stable interference cell strain
It infects preceding 1 day logarithmic growth phase PC9 cell in good condition and presses every 5 x10 of hole5It is a to be inoculated in 6 orifice plates.Infection
When, slow virus is diluted according to MOI=100, is separately added into hole containing 8 mgL-12 kinds of dilution restrovirus liquid 1mL of polybrene,
The target cell of blank is concurrently set as control.After cultivating 16h, it is changed to fresh DMEM complete medium 2mL and continues to cultivate,
Fluorescence microscopy microscopic observation efficiency of infection after 48h.Single cell suspension is made after metainfective cell is digested with pancreatin, according to every
The density that ware is 1000 is inoculated in the culture dish of 10cm, and culture selects monoclonal cell again to monoclonal cell group is formed
It is cloned, then picking sufficient amount monoclonal cell carries out amplification cultivation, prepares for detection in next step.Obtained stabilization
Interference cell is respectively designated as PC9/CXCR4-shRNA, and negative control cell is named as PC9/shRNAc.
1.2.7 QPCR detects cell PC-9mRNA jamming effectiveness
PC9/CXCR4-shRNA, PC9/shRNAc cell are collected, by QIAGEN Rneasy Mini kit kit explanation
Experimental method and step in book extract cell total rna, and according to reverse transcription reagent box (PrimeScript RT reagent
Kit the synthesis of cDNA reverse transcription) is carried out.Using this cDNA as template, PCR amplification, CXCR4 are carried out using PCR kit for fluorescence quantitative
It is synthesized with GAPDH gene (internal reference) primer by Sangon Biotech's design.CXCR4:Primer
(+): 5, GGAGAGTTGTAGGATTCTAC3,,Primer(-):5,CCTCGGTGTAGTTATCTGAAG3,.PCR reacts item
Part: 95 DEG C of 30s, 1 circulation, 55 DEG C of 30s40 circulations, 95 DEG C of 5s, 60 DEG C of 1min, 95 DEG C of 15s.CXCR4 base is indicated with 2^-ddCt value
Because of the relative expression levels of mRNA.
1.2.8 Western blot detects cell PC-9 albumen jamming effectiveness
PC9/CXCR4-shRNA, PC9/shRNAc cell are collected, cell pyrolysis liquid is added and cracks 10 min on ice, takes egg
Bai Shangqing BCA determination of protein concentration concentration.50~80g protein is taken to carry out 10%SDS-PAGE electrophoresis, the egg after separation
On white matter electrotransfer to pvdf membrane, 2 h are closed with the confining liquid room temperature containing 5% skimmed milk power;The diluted rabbit-anti of 1:2000 is added
People CXCR4 polyclonal antibody and the diluted mouse anti human GAPDH monoclonal antibody of 1:2000,4 DEG C of reactions are overnight;TBS washes film
Afterwards, it is separately added into the diluted secondary antibody of 1:3000 (goat antirabbit or goat anti-mouse IgG of HRP label), reacts at room temperature 2h; TBS
After washing, chemical illuminating reagent, cold CCD imaging system exposure, development and fixing is added.Scan film, to each protein band into
The analysis of row gray value indicates CXCR4 with the ratio of CXCR4 protein band gray value and internal reference GAPDH protein band gray value
The relative expression levels of albumen.
2 results
2.1 the PCR of recombinant slow virus plasmid and sequencing identification
PCR identify recombinant slow virus plasmid when, connect into shRNA segment positive colony PCR fragment size be 200bp.
PCR product is subjected to electrophoresis, the 1st, 2,3 pair of target sequence result shows positive colony (Fig1).From each target sequence
It respectively selects one in positive colony to be sequenced, as a result test result display sequence is correct.
The shRNA of 2.2 optimum jamming effects is screened
The mRNA expression of CXCR4 in 293 cell of each group is as shown in Fig. 2, as the result is shown: passing through single factor test variance point
Analysis, compared with blank control group, the expression of the CXCR4 of 293 cells in experimental group be remarkably decreased (P=0.0001 <
0.01), the CXCR4 expression of 293 cells of negative control vector group changes not statistically significant (P=0.192 > 0.05), says
Bright CXCR4-shRNA carrier can significantly lower the expression of CXCR4mRNA in 293 cells, and CXCR4-shRNA1 carrier is lowered most
Obviously.
The foregoing is merely presently preferred embodiments of the present invention, all equivalent changes done according to scope of the present invention patent with
Modification, is all covered by the present invention.
SEQUENCE LISTING
<110>Medical University Of Fujian
<120>construction method of CXCR4RNAi slow virus carrier
<130> 10
<160> 10
<170> PatentIn version 3.3
<210> 1
<211> 20
<212> DNA
<213>artificial sequence
<400> 1
ggagagttgt aggattctac 20
<210> 2
<211> 21
<212> DNA
<213>artificial sequence
<400> 2
cctcggtgta gttatctgaa g 21
<210> 3
<211> 59
<212> DNA
<213>shRNA1(Top)
<400> 3
gatccggatc agcatcgact ccttttcaag agaaaggagt cgatgctgat ccttttttg 59
<210> 4
<211> 59
<212> DNA
<213>shRNA1(Bottom)
<400> 4
aattcaaaaa aggatcagca tcgactcctt tctcttgaaa aggagtcgat gctgatccg 59
<210> 5
<211> 59
<212> DNA
<213>shRNA2(Top)
<400> 5
gatccggatc agtatataca cttcttcaag agagaagtgt atatactgat ccttttttg 59
<210> 6
<211> 59
<212> DNA
<213>shRNA2(Bottom)
<400> 6
aattcaaaaa aggatcagta tatacacttc tctcttgaag aagtgtatat actgatccg 59
<210> 7
<211> 59
<212> DNA
<213>shRNA3(Top)
<400> 7
gatccgcaag gcagtccatg tcatttcaag agaatgacat ggactgcctt gcttttttg 59
<210> 8
<211> 59
<212> DNA
<213>shRNA3(Bottom)
<400> 8
aattcaaaaa agcaaggcag tccatgtcat tctcttgaaa tgacatggac tgccttgcg 59
<210> 9
<211> 59
<212> DNA
<213>shRNAc(Top)
<400> 9
ccggtgcttc gacatttaac caatttcaag agaattggtt aaatgtcgaa gcttttttg 59
<210> 10
<211> 59
<212> DNA
<213>shRNAc(Bottom)
<400> 10
aattcaaaaa agcttcgaca tttaaccaat tctcttgaaa ttggttaaat gtcgaagca 59